Evidence map›Paper›PMID 33562011›Full record

ArticleCancers2021

Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis.

Carlo Augusto Mallio, Andrea Napolitano, Gennaro Castiello, Francesco Maria Giordano, Pasquale D'Alessio, Mario Iozzino, Yipeng Sun, Silvia Angeletti, Marco Russano, Daniele Santini and 4 more

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Carlo Augusto MallioDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID 0000-0002-0149-0801
Andrea NapolitanoDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, Italy.ORCID 0000-0002-7509-1555
Gennaro CastielloDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
Francesco Maria GiordanoDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID 0000-0002-3811-2484
Pasquale D'AlessioDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
Mario IozzinoDepartment of Interventional Radiology, S. Maria Goretti Hospital, 04100 Latina, Italy.
Yipeng SunInfervision Europe GmbH, Mainzer Strasse 75, D-65189 Wiesbaden, Germany.ORCID 0000-0002-1016-344X
Silvia AngelettiDepartmental Faculty of Medicine and Surgery, Unit of Clinical Laboratory Science, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
Marco RussanoDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, Italy.ORCID 0000-0002-6963-3864
Daniele SantiniDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, Italy.
Giuseppe ToniniDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, Italy.
Bruno Beomonte ZobelDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
Bruno VincenziDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, Italy.
Carlo Cosimo QuattrocchiDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) pneumonia and immune checkpoint inhibitor (ICI) therapy-related pneumonitis share common features. The aim of this study was to determine on chest computed tomography (CT) images whether a deep convolutional neural network algorithm is able to solve the challenge of differential diagnosis between COVID-19 pneumonia and ICI therapy-related pneumonitis.

methodsWe enrolled three groups: a pneumonia-free group (

resultsThe algorithm showed low specificity in distinguishing COVID-19 from ICI therapy-related pneumonitis (sensitivity 97.1%, specificity 14.3%, area under the curve (AUC) = 0.62). ICI therapy-related pneumonitis was identified by the AI when compared to pneumonia-free controls (sensitivity = 85.7%, specificity 100%, AUC = 0.97).

conclusionsThe deep learning algorithm is not able to distinguish between COVID-19 pneumonia and ICI therapy-related pneumonitis. Awareness must be increased among clinicians about imaging similarities between COVID-19 and ICI therapy-related pneumonitis. ICI therapy-related pneumonitis can be applied as a challenge population for cross-validation to test the robustness of AI models used to analyze interstitial pneumonias of variable etiology.

Indexed as

artificial intelligencechest CTCOVID-19deep learningdrug-induced pneumonitisimmune checkpoint inhibitors therapy

Identifiers

PMID33562011
PMCPMC7914551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.